Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata patients have higher risks of infections, lymphoma, heart issues, and death.

The research found how certain drugs and polymers form stable complexes, which could help develop new pharmaceutical forms.

Ritlecitinib shows promise for treating alopecia areata, especially with early and extended treatment.

Patients prefer the higher 50 mg dose of ritlecitinib for better hair regrowth despite higher risks.

Adults and adolescents with severe alopecia areata are willing to take significant health risks for a better chance of hair regrowth.

The study used monkeys to test a hair loss treatment called minoxidil, which showed positive results.

Brevilin-A is a safe and effective treatment for mild to moderate alopecia areata in children.

Ritlecitinib shows promise for hair regrowth in alopecia areata patients.

Baricitinib helped regrow hair in patients with severe alopecia areata after other treatments failed.

Baricitinib helps regrow hair in adults with severe alopecia better than a placebo and is approved for treatment, but long-term effects are still unknown.

JAK inhibitors show promise for treating alopecia areata, but more research is needed.

Tofacitinib may effectively treat hair loss and improve symptoms in autoimmune conditions like alopecia areata and Sjögren's syndrome, but long-term treatment might be necessary.

Genetics influence opioid addiction risk, diet affects COVID-19 severity, Aerva lanata may harm kidneys, some plants fight fungi and cancer, and nursing students need better contraceptive knowledge.

Previous alopecia areata treatments do not affect the long-term effectiveness of ritlecitinib.

The EQ-5D-5L tool may not accurately measure the impact of alopecia areata on patients' lives.

Significant, lasting hair regrowth is needed to improve how patients with Alopecia Areata feel about their condition.

Oral tofacitinib effectively treats alopecia areata long-term with manageable side effects.

TRM21 helps control flavonoid production and root hair growth in Arabidopsis thaliana.

KF19418 promotes hair growth similarly to minoxidil but is not better in live mice.

NGF-modified hair follicle stem cells may help treat Alzheimer's by improving brain function and reducing harmful proteins.

In Denmark from 1995 to 2016, hospital-treated alopecia areata cases increased, mostly affecting women and those over 50.

More severe hair loss in alopecia areata greatly impacts patients and caregivers.

Targeting vitamin D and androgen receptors may effectively treat triple-negative breast cancer, especially with chemotherapy.

Diazoxide applied to the skin can increase hair growth without harmful side effects.

Keratin 15 affects cell behavior and characteristics in skin cells.

Doctors in the Middle East need better treatments and more knowledge about new therapies for hair loss condition Alopecia Areata.

Prenatal stress changes how male and female rats enjoy rewards differently, linked to sex hormones.

The research shows how certain drug molecules form stable structures with polymers, which could help create new drug forms.

Mutations in the SRD5A3 gene cause a new type of glycosylation disorder by blocking the production of a molecule necessary for protein glycosylation.

Better standardization and transparency in statistical reporting are needed to improve hair care research quality.